Immutep (IMMP) Payables (2011 - 2025)
Immutep's (IMMP) quarterly Payables came in at $30.2 million in Q4 2025, up 531.86% YoY from $4.8 million in Q4 2024, and up 343.53% on a QoQ basis from $6.8 million in Q2 2025.
Immutep (IMMP) Payables (2011 - 2025) Analysis & Trends
Immutep (IMMP) has 15 years of Payables data on file, last reported at $30.2 million in Q4 2025.
- Quarterly Payables rose 531.86% year-over-year to $30.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.2 million (up 531.86% YoY) and the FY2025 annual result came in at $6.8 million, up 8.08% from the prior year.
- Payables grew to $30.2 million in Q4 2025, from $6.8 million in the prior quarter.
- In the past five years, Payables ranged from a high of $30.2 million in Q4 2025 to a low of $3.7 million in Q2 2021.
- A 5-year average of $7.6 million and a median of $5.2 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables declined 25.99% — and 2025, when it jumped 531.86%.
- Tracing IMMP's Payables over 5 years: stood at $5.3 million in 2021, then decreased by 2.28% to $5.2 million in 2022, then decreased by 25.99% to $3.8 million in 2023, then gained by 25.03% to $4.8 million in 2024, then surged by 531.86% to $30.2 million in 2025.
- The last three Payables figures came in at $30.2 million (Q4 2025), $6.8 million (Q2 2025), and $4.8 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 35.57 Mn |
| 10 | Immutep | 55.93 Mn | -9.15 Mn | - | 30.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.21 Mn |
| Jun 30, 2025 | 6.81 Mn |
| Dec 31, 2024 | 4.78 Mn |
| Jun 30, 2024 | 6.30 Mn |
| Dec 31, 2023 | 3.82 Mn |
| Jun 30, 2023 | 6.03 Mn |
| Dec 31, 2022 | 5.17 Mn |
| Jun 30, 2022 | 4.12 Mn |
| Dec 31, 2021 | 5.29 Mn |
| Jun 30, 2021 | 3.68 Mn |
| Dec 31, 2020 | 3.49 Mn |
| Jun 30, 2020 | 1.92 Mn |
| Dec 31, 2019 | 2.47 Mn |
| Jun 30, 2019 | 3.54 Mn |
| Dec 31, 2018 | 2.85 Mn |
| Jun 30, 2018 | 1.22 Mn |
| Jun 30, 2017 | 1.94 Mn |
| Mar 31, 2017 | 922,578.89 |
| Jun 30, 2016 | 1.06 Mn |
| Jun 30, 2015 | 2.15 Mn |